Giá của Scilex Holding Company là bao nhiêu (SCLX)

Giá của Scilex Holding Company (SCLX) là $5.61

Mũ thị trường của Scilex Holding Company là gì (SCLX)

Giới hạn thị trường của Scilex Holding Company (SCLX) là $47.65M

Scilex Holding Company (SCLX) EPS

Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.

Năm	EPS	Thay đổi
Không đủ dữ liệu cho ngày được cung cấp.

Năm

EPS

Thay đổi

Không đủ dữ liệu cho ngày được cung cấp.

Công ty	EPS	Chênh lệch EPS	Quốc gia
Eli Lilly and Company LLY.US	$29.85	-	US
Johnson & Johnson JNJ.US	$8.65	-	US
AbbVie Inc. ABBV.US	$3.55	-	US
Roche Holding AG RO.SW	$20.39	-	CH
Merck & Co., Inc. MRK.US	$1.26	-	US

Công ty

EPS

Chênh lệch EPS

Quốc gia